Furthermore, since T2DM is a risk factor for pancreatic disease, it can be difficult to differentiate whether pancreatitis or pancreatic cancer is attributable to the underlying condition or the GLP‐1 RA. This evidence concerns the gene GLP1R and familial pancreatic carcinoma.